BRTX
$0.25
BioRestorative Therapies, Inc.
Recent News
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates
Monte Rosa Therapeutics (GLUE) delivered earnings and revenue surprises of -17.02% and -72.90%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
BC-Most Active Stocks
Elong Power Holding Ltd. 356,032,309 0.0734
BioRestorative (BRTX) Earnings Call Transcript
Need a quote from a Motley Fool analyst? On behalf of the management team and everyone at BioRestorative Therapies, I would like to thank you for your interest in our company. With that said, I'd like to ask Robert Eugene Kristal, our CFO, to provide a brief overview of our third-quarter financial results.
BioRestorative Therapies Inc (BRTX) Q3 2025 Earnings Call Highlights: Strategic Advancements ...
BioRestorative Therapies Inc (BRTX) secures FDA fast track for BRTX 100, strengthens commercial infrastructure, but faces revenue decline and increased net loss.
Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of 0.00% and -97.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?